Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hoelzer

Showing results (371-380 of 415) with videos related to

Pageof 42
Sort By:
International Archives of Allergy and Applied Immunology|January 1, 1990
Histamine release from basophils after in vivo application of recombinant human interleukin-3 in manR D Merget, A B Maurer, U Koch, et al.
Annals of Hematology|October 24, 2000
Induction of apoptosis using 2',2' difluorodeoxycytidine (gemcitabine) in combination with antimetabolites or anthracyclines on malignant lymphatic and myeloid cells. Antagonism or synergism depends on incubation schedule and origin of neoplastic cellsK U Chow, J Ries, E Weidmann, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|June 26, 2001
Deregulated expression of prostate apoptosis response gene-4 in less differentiated lymphocytes and inverse expressional patterns of par-4 and bcl-2 in acute lymphocytic leukemiaS Boehrer, K U Chow, E Puccetti, et al.
Annals of Hematology|April 22, 1999
Treatment of patients with low-risk myelodysplastic syndromes using a combination of all-trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factorW K Hofmann, A Ganser, G Seipelt, et al.
British Journal of Haematology|October 29, 1998
Detection of karyotypic aberrations in acute myeloblastic leukaemia: a prospective comparison between PCR/FISH and standard cytogenetics in 140 patients with de novo AMLJ Krauter, W Peter, U Pascheberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 1999
Treatment of mantle-cell lymphomas with intermittent two-hour infusion of cladribine as first-line therapy or in first relapseM J Rummel, K U Chow, E Jäger, et al.
Annals of Internal Medicine|September 15, 1995
Long-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplantation. The Acute Lymphoblastic Leukemia Working CommitteeM J Zhang, D Hoelzer, M M Horowitz, et al.
Leukemia|June 11, 2010
BAALC-associated gene expression profiles define IGFBP7 as a novel molecular marker in acute leukemiaS Heesch, C Schlee, M Neumann, et al.
Leukemia & Lymphoma|April 28, 2000
Induction of apoptosis by 2-chloro-2'deoxyadenosine (2-CdA) alone and in combination with other cytotoxic drugs: synergistic effects on normal and neoplastic lymphocytes by addition of doxorubicin and mitoxantroneK U Chow, M J Rummel, E Weidmann, et al.
British Journal of Haematology|December 1, 1996
Prognostic significance of additional chromosome abnormalities in adult patients with Philadelphia chromosome positive acute lymphoblastic leukaemiaH Rieder, W D Ludwig, W Gassmann, et al.
Pageof 42

Showing results (371-380 of 415) with videos related to

Sort By:
Pageof 42
International Archives of Allergy and Applied Immunology|January 1, 1990
Histamine release from basophils after in vivo application of recombinant human interleukin-3 in manR D Merget, A B Maurer, U Koch, et al.
Annals of Hematology|October 24, 2000
Induction of apoptosis using 2',2' difluorodeoxycytidine (gemcitabine) in combination with antimetabolites or anthracyclines on malignant lymphatic and myeloid cells. Antagonism or synergism depends on incubation schedule and origin of neoplastic cellsK U Chow, J Ries, E Weidmann, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|June 26, 2001
Deregulated expression of prostate apoptosis response gene-4 in less differentiated lymphocytes and inverse expressional patterns of par-4 and bcl-2 in acute lymphocytic leukemiaS Boehrer, K U Chow, E Puccetti, et al.
Annals of Hematology|April 22, 1999
Treatment of patients with low-risk myelodysplastic syndromes using a combination of all-trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factorW K Hofmann, A Ganser, G Seipelt, et al.
British Journal of Haematology|October 29, 1998
Detection of karyotypic aberrations in acute myeloblastic leukaemia: a prospective comparison between PCR/FISH and standard cytogenetics in 140 patients with de novo AMLJ Krauter, W Peter, U Pascheberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 1999
Treatment of mantle-cell lymphomas with intermittent two-hour infusion of cladribine as first-line therapy or in first relapseM J Rummel, K U Chow, E Jäger, et al.
Annals of Internal Medicine|September 15, 1995
Long-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplantation. The Acute Lymphoblastic Leukemia Working CommitteeM J Zhang, D Hoelzer, M M Horowitz, et al.
Leukemia|June 11, 2010
BAALC-associated gene expression profiles define IGFBP7 as a novel molecular marker in acute leukemiaS Heesch, C Schlee, M Neumann, et al.
Leukemia & Lymphoma|April 28, 2000
Induction of apoptosis by 2-chloro-2'deoxyadenosine (2-CdA) alone and in combination with other cytotoxic drugs: synergistic effects on normal and neoplastic lymphocytes by addition of doxorubicin and mitoxantroneK U Chow, M J Rummel, E Weidmann, et al.
British Journal of Haematology|December 1, 1996
Prognostic significance of additional chromosome abnormalities in adult patients with Philadelphia chromosome positive acute lymphoblastic leukaemiaH Rieder, W D Ludwig, W Gassmann, et al.
Pageof 42